Abbott Laboratories (ABT) Earnings Date, Estimates & Call Transcripts $132.41 +0.41 (+0.31%) Closing price 03:59 PM EasternExtended Trading$132.52 +0.11 (+0.09%) As of 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Abbott Laboratories Earnings Summary Abbott Laboratories posted Q2 2025 earnings on July 17, 2025, reporting an EPS of $1.26, which hit the consensus estimate of $1.26. Quarterly revenue rose 7.4% year-over-year to $11.14 billion, above analysts' expectations of $11.01 billion. With a trailing EPS of $7.98 and a P/E Ratio of 16.59, Abbott Laboratories' earnings are expected to grow 11.48% next year, from $5.14 to $5.73 per share. Upcoming Q3 Earnings DateOct. 15Before Market OpensEstimatedConsensus EPS (Jul. 17) $1.26 Actual EPS (Jul. 17) $1.26 Actual Revenue (Jul. 17) $11.14BQ2 2025 Earnings ResourcesQ2 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Slide Deck Quarterly Report (10-Q)ABT Upcoming EarningsAbbott Laboratories' next earnings date is estimated for Wednesday, October 15, 2025, based on past reporting schedules. Slide DeckFull Screen Slide DeckPowered by Get Abbott Laboratories Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Abbott Laboratories and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataABT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ABT Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Abbott Laboratories Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany EPS GuidanceQ1 20252$1.07$1.26$1.171.050 - 1.090Q2 20253$1.23$1.26$1.251.230 - 1.270Q3 20253$1.24$1.33$1.291.280 - 1.320Q4 20252$1.47$1.53$1.50 FY 2025 10 $5.01 $5.38 $5.21 Q1 20262$1.17$1.23$1.20Q2 20262$1.38$1.39$1.39Q3 20262$1.43$1.49$1.46Q4 20262$1.61$1.63$1.62 Abbott Laboratories Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 10/15/2025(Estimated)--------7/17/2025Q2 2025$1.26$1.26-$1.01$11.01B$11.14B4/16/2025Q1 2025$1.07$1.09+$0.02$0.76$10.38B$10.36B1/22/2025Q4 2024$1.34$1.34-$5.27$11.03B$10.97B10/16/2024Q3 2024$1.20$1.21+$0.01$1.48$10.55B$10.64B7/18/2024Q2 2024$1.10$1.14+$0.04$1.54$10.37B$10.38B4/17/2024Q1 2024$0.96$0.98+$0.02$1.26$9.88B$9.96B1/24/2024Q4 2023$1.19$1.19-$1.47$10.19B$10.24B10/18/2023Q3 2023$1.10$1.14+$0.04$1.46$9.82B$10.14B Abbott Laboratories Earnings - Frequently Asked Questions When is Abbott Laboratories' earnings date? Abbott Laboratories has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, October 15th, 2025 based off last year's report dates. Learn more on ABT's earnings history. What guidance has Abbott Laboratories issued on next quarter's earnings? Abbott Laboratories updated its third quarter 2025 earnings guidance on Thursday, July, 17th. The company provided earnings per share guidance of 1.280-1.320 for the period, compared to the consensus EPS estimate of 1.338. The company issued revenue guidance of -. Did Abbott Laboratories beat their earnings estimates last quarter? In the previous quarter, Abbott Laboratories (NYSE:ABT) reported $1.26 earnings per share (EPS) to hit the analysts' consensus estimate of $1.26. Learn more on analysts' earnings estimate vs. ABT's actual earnings. How can I listen to Abbott Laboratories' earnings conference call? The conference call for Abbott Laboratories' latest earnings report can be listened to online. Listen to Conference Call How can I read Abbott Laboratories' conference call transcript? The conference call transcript for Abbott Laboratories' latest earnings report can be read online. Read Transcript How much revenue does Abbott Laboratories generate each year? Abbott Laboratories (NYSE:ABT) has a recorded annual revenue of $41.95 billion. How much profit does Abbott Laboratories generate each year? Abbott Laboratories (NYSE:ABT) has a recorded net income of $13.40 billion. ABT has generated $7.98 earnings per share over the last four quarters. What is Abbott Laboratories' price-to-earnings ratio? Abbott Laboratories (NYSE:ABT) has a trailing price-to-earnings ratio of 16.59 and a forward price-to-earnings ratio of 25.76. The price/earnings-to-growth ratio is 2.5. What is Abbott Laboratories' EPS forecast for next year? Abbott Laboratories' earnings are expected to grow from $5.14 per share to $5.73 per share in the next year, which is a 11.48% increase. More Earnings Resources from MarketBeat Related Companies DXCM Earnings ISRG Earnings TSLA Earnings ABBV Earnings BSX Earnings ELV Earnings ITGR Earnings JNJ Earnings MDT Earnings TMO Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles After Earnings Miss, Walmart Is Still a Top Consumer Staples PlayRoyal Caribbean Earnings Beat Fuels Strong 2025 OutlookDLocal Stock Soars 43% After Earnings Beat and Raised GuidanceGreen Dot's 30% Rally: Turnaround Takes Off on Explosive EarningsElbit Systems Jumps on Record Earnings and a $1.6B ContractBrinker Serves Up Earnings Beat, Sidesteps Cost PressuresWhy BigBear.ai Stock's Dip on Earnings Can Be an Opportunity This page (NYSE:ABT) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abbott Laboratories Please log in to your account or sign up in order to add this asset to your watchlist. Share Abbott Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access